Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page’s revision label in the footer updated from v3.5.3 to v3.5.4, indicating a minor update to the record history.
    Difference
    0.1%
    Check dated 2026-05-14T23:06:27.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The Record History shows a new revision, v3.5.3, replacing the previous v3.5.2, signaling an update to the record history. This indicates an update to the record history rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-04-30T15:47:26.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added to the history and revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:50:36.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the history and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T21:05:32.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    New revision entry v3.4.3 is added and v3.4.2 is removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:02:20.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history. Notices about government funding and operating status were removed.
    Difference
    0.8%
    Check dated 2026-02-11T02:07:35.000Z thumbnail image

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.